Skip to content

Prevention of Postpartum Haemorrhage

Tranexamic Acid for the Prevention of Postpartum Haemorrhage

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04463966
Enrollment
100
Registered
2020-07-09
Start date
2020-04-30
Completion date
2021-05-31
Last updated
2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Partum Hemorrhage

Keywords

tranexamic acid, postpartum hemorrhage, cesarean section

Brief summary

Use of Tranexamic Acid for prevention of Postpartum hemorrhage in high risk patients: Randomized Control Trial

Detailed description

This study aims to assess the efficacy of administration of Tranexamic Acid in preventing Postpartum haemorrhage & reducing intraoperative and postoperative blood loss in high risk women for Postpartum Hemorrhage undergoing caesarean section. Studying its benefit to transfusion-sparing and hysterectomy-sparing. & reduction of hemorrhage-related mortality when Postpartum hemorrhage is expected.

Interventions

DRUGTranexamic acid injection

1 gm (100 mg/ml) slowly intravenous infusion during delivery ( administered over 10 minutes at 1 ml/minute) .

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Women at high risk for postpartum hemorrhage after cesarean section

Exclusion criteria

* women who are not at high risk for postpartum hemorrhage , or attending for normal vaginal delivery.

Design outcomes

Primary

MeasureTime frameDescription
blood lossimmediately after deliverEstimation of blood loss

Secondary

MeasureTime frameDescription
blood pressureimmediately after deliveryblood pressure
pulseimmediately after deliverypulse
temperatureimmeditely after deliverytemperature

Countries

Egypt

Contacts

Primary ContactAboubakr Elnashar, MD
elnashar53@hotmail.com00201066934749
Backup Contactshaimaa ezzat
00201009023289

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026